GEORGE YANCOPOULOS Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEORGE YANCOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGE YANCOPOULOS. GEORGE YANCOPOULOS is EVP, CSO, & Pres Regn Res Labs in REGENERON PHARMACEUTICALS INC ($REGN) and President & CSO in REGENERON PHARMACEUTICALS INC ($REGN) and President and Chief Scientific in REGENERON PHARMACEUTICALS INC ($REGN) and President and CSO in REGENERON PHARMACEUTICALS INC ($REGN) and President Regeneron Laboratori in REGENERON PHARMACEUTICALS INC ($REGN).
GEORGE YANCOPOULOS in REGENERON PHARMACEUTICALS, INC.
Trading Symbol: REGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEORGE YANCOPOULOS: President and Chief Scientific, President and CSO, President & CSO, President Regeneron Laboratori, EVP, CSO, & Pres Regn Res Labs
Holdings: 880,938 shares
Current Value: $315,102,713
Latest Transaction: Dec 31 2020
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GEORGE YANCOPOULOS in REGENERON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 52.03 | 158,079 | 8,224,850 | 0 | |
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 52.03 | 240,000 | 12,487,200 | 158,079 | |
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 57,465 | 0 | 0 | 57.5 K to 0 (-100.00 %) |
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 483.25 | 86,096 | 41,605,892 | 822,207 | 908.3 K to 822.2 K (-9.48 %) |
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 52.03 | 158,079 | 8,224,850 | 908,303 | 750.2 K to 908.3 K (+21.07 %) |
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 483.25 | 130,714 | 63,167,541 | 750,224 | 880.9 K to 750.2 K (-14.84 %) |
Dec 31 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 52.03 | 240,000 | 12,487,200 | 880,938 | 640.9 K to 880.9 K (+37.45 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 30.63 | 150,000 | 4,594,500 | 0 | |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 30.63 | 96,736 | 2,963,024 | 150,000 | |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 486.31 | 7 | 3,404 | 517,799 | 517.8 K to 517.8 K (0.00 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 485.63 | 1,693 | 822,172 | 517,806 | 519.5 K to 517.8 K (-0.33 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 484.72 | 345 | 167,228 | 519,499 | 519.8 K to 519.5 K (-0.07 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 483.80 | 355 | 171,749 | 519,844 | 520.2 K to 519.8 K (-0.07 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 481.68 | 100 | 48,168 | 520,199 | 520.3 K to 520.2 K (-0.02 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 480.34 | 60 | 28,820 | 520,299 | 520.4 K to 520.3 K (-0.01 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 479.60 | 1,651 | 791,820 | 520,359 | 522 K to 520.4 K (-0.32 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 478.43 | 1,469 | 702,814 | 522,010 | 523.5 K to 522 K (-0.28 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 477.50 | 4,735 | 2,260,963 | 523,479 | 528.2 K to 523.5 K (-0.90 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 476.51 | 7,197 | 3,429,442 | 528,214 | 535.4 K to 528.2 K (-1.34 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 475.43 | 4,223 | 2,007,741 | 535,411 | 539.6 K to 535.4 K (-0.78 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 474.52 | 7,060 | 3,350,111 | 539,634 | 546.7 K to 539.6 K (-1.29 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 473.39 | 8,024 | 3,798,481 | 546,694 | 554.7 K to 546.7 K (-1.45 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 472.56 | 10,270 | 4,853,191 | 554,718 | 565 K to 554.7 K (-1.82 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 471.34 | 5,258 | 2,478,306 | 564,988 | 570.2 K to 565 K (-0.92 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 470.48 | 5,531 | 2,602,225 | 570,246 | 575.8 K to 570.2 K (-0.96 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 469.46 | 7,250 | 3,403,585 | 575,777 | 583 K to 575.8 K (-1.24 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 468.49 | 8,542 | 4,001,842 | 583,027 | 591.6 K to 583 K (-1.44 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 467.53 | 10,023 | 4,686,053 | 591,569 | 601.6 K to 591.6 K (-1.67 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 466.58 | 11,916 | 5,559,767 | 601,592 | 613.5 K to 601.6 K (-1.94 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 465.45 | 7,068 | 3,289,801 | 613,508 | 620.6 K to 613.5 K (-1.14 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 464.59 | 5,099 | 2,368,944 | 620,576 | 625.7 K to 620.6 K (-0.81 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 463.54 | 5,463 | 2,532,319 | 625,675 | 631.1 K to 625.7 K (-0.87 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 462.43 | 3,317 | 1,533,880 | 631,138 | 634.5 K to 631.1 K (-0.52 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 461.79 | 1,159 | 535,215 | 634,455 | 635.6 K to 634.5 K (-0.18 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 476.42 | 78,376 | 37,339,894 | 635,614 | 714 K to 635.6 K (-10.98 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 30.63 | 150,000 | 4,594,500 | 713,990 | 564 K to 714 K (+26.60 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 476.42 | 50,545 | 24,080,649 | 563,990 | 614.5 K to 564 K (-8.22 %) |
Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 30.63 | 96,736 | 2,963,024 | 614,535 | 517.8 K to 614.5 K (+18.68 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 0.00 | 25,155 | 0 | 25,155 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 372.46 | 81,278 | 30,272,804 | 81,278 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | M | 21.25 | 150,000 | 3,187,500 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | M | 21.25 | 95,295 | 2,025,019 | 150,000 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | G | 0.00 | 23,367 | 0 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | G | 0.00 | 23,367 | 0 | 23,367 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 325,986 | 0 | 0 | 326 K to 0 (-100.00 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 2,366 | 0 | 325,989 | 328.4 K to 326 K (-0.72 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 75,036 | 0 | 328,352 | 253.3 K to 328.4 K (+29.62 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 500,000 | 0 | 253,316 | 753.3 K to 253.3 K (-66.37 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 150,722 | 0 | 753,316 | 602.6 K to 753.3 K (+25.01 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 150,722 | 0 | 249,278 | 400 K to 249.3 K (-37.68 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 75,036 | 0 | 0 | 75 K to 0 (-100.00 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Payment of Exercise | F | 377.16 | 77,767 | 29,330,602 | 444,109 | 521.9 K to 444.1 K (-14.90 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Buy | M | 21.25 | 150,000 | 3,187,500 | 521,876 | 371.9 K to 521.9 K (+40.34 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Payment of Exercise | F | 377.16 | 49,405 | 18,633,590 | 371,876 | 421.3 K to 371.9 K (-11.73 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Buy | M | 21.25 | 95,295 | 2,025,019 | 421,281 | 326 K to 421.3 K (+29.23 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 325,986 | 0 | 325,986 | 0 to 326 K |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 94,048 | 1,580,006 | 0 | |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 150,000 | 2,520,000 | 94,048 | |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 602,594 | 483.6 K to 602.6 K (+24.61 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 0 | 119 K to 0 (-100.00 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 48,192 | 18,183,324 | 118,993 | 167.2 K to 119 K (-28.83 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 94,048 | 1,580,006 | 167,185 | 73.1 K to 167.2 K (+128.59 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 76,863 | 29,001,179 | 73,137 | 150 K to 73.1 K (-51.24 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 150,000 | 2,520,000 | 150,000 | 0 to 150 K |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 381.40 | 129,013 | 49,205,558 | 129,013 | |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,176 | 0 | 483,601 | 484.8 K to 483.6 K (-0.24 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 3,211 | 0 | 484,777 | 488 K to 484.8 K (-0.66 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 847 | 0 | 487,988 | 487.1 K to 488 K (+0.17 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 101,187 | 0 | 487,141 | 386 K to 487.1 K (+26.22 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 299,134 | 0 | 385,954 | 86.8 K to 386 K (+344.55 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 400,000 | 0 | 86,820 | 486.8 K to 86.8 K (-82.17 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 242,150 | 0 | 486,820 | 244.7 K to 486.8 K (+98.97 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,264 | 0 | 244,670 | 155.4 K to 244.7 K (+57.44 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 155,406 | 331.6 K to 155.4 K (-53.14 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 331,629 | 155.4 K to 331.6 K (+113.40 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,427 | 0 | 159,324 | 69.9 K to 159.3 K (+127.94 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,921 | 0 | 569,897 | 568 K to 569.9 K (+0.34 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 43,348 | 0 | 612,936 | 569.6 K to 612.9 K (+7.61 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 101,187 | 0 | 75,036 | 176.2 K to 75 K (-57.42 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 176,223 | 0 to 176.2 K |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 24,643 | 0 | 0 | 24.6 K to 0 (-100.00 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 299,134 | 0 | 24,643 | 323.8 K to 24.6 K (-92.39 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 323,777 | 500 K to 323.8 K (-35.24 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 847 | 0 | 0 | 847 to 0 (-100.00 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 242,150 | 0 | 847 | 243 K to 847 (-99.65 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,264 | 0 | 500,847 | 590.1 K to 500.8 K (-15.13 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,427 | 0 | 500,000 | 589.4 K to 500 K (-15.17 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,921 | 0 | 500,000 | 501.9 K to 500 K (-0.38 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 43,348 | 0 | 500,000 | 543.3 K to 500 K (-7.98 %) |
Dec 20 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Payment of Exercise | F | 386.90 | 257,850 | 99,762,165 | 422,762 | 680.6 K to 422.8 K (-37.89 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Option Exercise | A | 378.98 | 139,474 | 52,857,857 | 139,474 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Option Exercise | M | 21.92 | 195,438 | 4,284,001 | 0 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Payment of Exercise | F | 385.08 | 95,050 | 36,601,854 | 680,612 | 775.7 K to 680.6 K (-12.25 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Payment of Exercise | F | 385.08 | 11,124 | 4,283,630 | 775,662 | 786.8 K to 775.7 K (-1.41 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Buy | M | 21.92 | 195,438 | 4,284,001 | 786,786 | 591.3 K to 786.8 K (+33.05 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 381.92 | 146,815 | 56,071,585 | 146,815 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 20.32 | 195,079 | 3,964,005 | 0 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 500,000 | 0 | 67,976 | 568 K to 68 K (-88.03 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 380.09 | 95,223 | 36,193,310 | 591,348 | 686.6 K to 591.3 K (-13.87 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 380.09 | 10,429 | 3,963,959 | 686,571 | 697 K to 686.6 K (-1.50 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 20.32 | 195,079 | 3,964,005 | 697,000 | 501.9 K to 697 K (+38.87 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 555.67 | 146,815 | 81,580,691 | 146,815 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 52.03 | 1,921 | 99,950 | 501,921 | 500 K to 501.9 K (+0.38 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 1,612 | 0 | 567,976 | 569.6 K to 568 K (-0.28 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 555.26 | 1,900 | 1,054,994 | 500,000 | 501.9 K to 500 K (-0.38 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 554.58 | 1,101 | 610,593 | 501,900 | 503 K to 501.9 K (-0.22 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 553.32 | 1,600 | 885,312 | 503,001 | 504.6 K to 503 K (-0.32 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 552.54 | 3,625 | 2,002,958 | 504,601 | 508.2 K to 504.6 K (-0.71 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 551.43 | 4,992 | 2,752,739 | 508,226 | 513.2 K to 508.2 K (-0.97 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 550.47 | 6,390 | 3,517,503 | 513,218 | 519.6 K to 513.2 K (-1.23 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 549.57 | 4,407 | 2,421,955 | 519,608 | 524 K to 519.6 K (-0.84 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 548.49 | 3,780 | 2,073,292 | 524,015 | 527.8 K to 524 K (-0.72 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 547.45 | 914 | 500,369 | 527,795 | 528.7 K to 527.8 K (-0.17 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 546.36 | 3,038 | 1,659,842 | 528,709 | 531.7 K to 528.7 K (-0.57 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 545.51 | 5,611 | 3,060,857 | 531,747 | 537.4 K to 531.7 K (-1.04 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 544.52 | 4,290 | 2,335,991 | 537,358 | 541.6 K to 537.4 K (-0.79 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 543.57 | 602 | 327,229 | 541,648 | 542.3 K to 541.6 K (-0.11 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 542.72 | 1,098 | 595,907 | 542,250 | 543.3 K to 542.3 K (-0.20 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 11.64 | 182,818 | 2,128,002 | 0 | |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 580.29 | 400 | 232,116 | 543,348 | 543.7 K to 543.3 K (-0.07 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 579.53 | 1,500 | 869,295 | 543,748 | 545.2 K to 543.7 K (-0.28 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 578.73 | 268 | 155,100 | 545,248 | 545.5 K to 545.2 K (-0.05 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 577.58 | 1,996 | 1,152,850 | 545,516 | 547.5 K to 545.5 K (-0.36 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 576.48 | 865 | 498,655 | 547,512 | 548.4 K to 547.5 K (-0.16 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 575.64 | 2,441 | 1,405,137 | 548,377 | 550.8 K to 548.4 K (-0.44 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 574.55 | 2,693 | 1,547,263 | 550,818 | 553.5 K to 550.8 K (-0.49 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 573.47 | 2,629 | 1,507,653 | 553,511 | 556.1 K to 553.5 K (-0.47 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 572.43 | 5,723 | 3,276,017 | 556,140 | 561.9 K to 556.1 K (-1.02 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 571.41 | 7,800 | 4,456,998 | 561,863 | 569.7 K to 561.9 K (-1.37 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 570.67 | 6,330 | 3,612,341 | 569,663 | 576 K to 569.7 K (-1.10 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 569.47 | 2,223 | 1,265,932 | 575,993 | 578.2 K to 576 K (-0.38 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 568.49 | 1,600 | 909,584 | 578,216 | 579.8 K to 578.2 K (-0.28 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 567.61 | 1,350 | 766,274 | 579,816 | 581.2 K to 579.8 K (-0.23 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 566.66 | 1,700 | 963,322 | 581,166 | 582.9 K to 581.2 K (-0.29 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 565.89 | 1,000 | 565,890 | 582,866 | 583.9 K to 582.9 K (-0.17 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 564.57 | 1,000 | 564,570 | 583,866 | 584.9 K to 583.9 K (-0.17 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 563.76 | 530 | 298,793 | 584,866 | 585.4 K to 584.9 K (-0.09 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 562.36 | 100 | 56,236 | 585,396 | 585.5 K to 585.4 K (-0.02 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 561.75 | 1,200 | 674,100 | 585,496 | 586.7 K to 585.5 K (-0.20 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 559.08 | 92,316 | 51,612,029 | 586,696 | 679 K to 586.7 K (-13.60 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 559.08 | 3,806 | 2,127,858 | 679,012 | 682.8 K to 679 K (-0.56 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 11.64 | 182,818 | 2,128,002 | 682,818 | 500 K to 682.8 K (+36.56 %) |
Sep 19 2003 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | EVP, CSO, & Pres Re ... | Option Exercise | M | 4.25 | 87,060 | 370,005 | 0 | |
Sep 19 2003 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | EVP, CSO, & Pres Re ... | Option Exercise | M | 4.25 | 34,250 | 145,563 | 0 | |
Sep 19 2003 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | EVP, CSO, & Pres Re ... | Option Exercise | M | 4.00 | 5,000 | 20,000 | 0 | |
Sep 19 2003 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | EVP, CSO, & Pres Re ... | Sell | S | 20.70 | 300 | 6,210 | 80,751 | 81.1 K to 80.8 K (-0.37 %) |